These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31142231)

  • 1. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
    Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
    J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
    Garrelts JC; Godley PJ; Horton MW; Karboski JA
    Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
    Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
    Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin.
    Rodvold KA; Blum RA
    J Clin Pharmacol; 1987; 27(5):419-24. PubMed ID: 3693587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
    Wrishko RE; Levine M; Khoo D; Abbott P; Hamilton D
    Ther Drug Monit; 2000 Oct; 22(5):522-31. PubMed ID: 11034256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
    Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
    Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
    J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin monitoring: one or two serum levels?
    Andrés I; López R; Pou L; Piñol F; Pascual C
    Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].
    Nakamura T; Wakaki N; Kimura Y; Goto N; Masada M
    Yakugaku Zasshi; 1996 Nov; 116(11):876-83. PubMed ID: 8981831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
    Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
    Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
    Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
    Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
    AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Br J Clin Pharmacol; 1989 Jul; 28(1):37-44. PubMed ID: 2775614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
    Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
    J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function.
    Platt DR; Matthews SJ; Sevka MJ; Comer JB; Quintiliani R; Cunha BA; Nightingale CH; Chow MS
    Clin Pharm; 1982; 1(4):361-5. PubMed ID: 7185531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Bayesian Area Under the Concentration-Time Curve-Based Pharmacokinetic Dosing Based on a One-Compartment Model and Trough-Only Monitoring for Vancomycin.
    Salehpour N; Riley LD; Gonzales MJ; Kobic E; Nix DE
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0017223. PubMed ID: 37133362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
    Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
    Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.